Clinical Trials in Portland

Showing 1641-1660 of 8,670 trials

RECRUITING< 1 mile

Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

NCT06562777

This study aims to learn more about symptoms that patients experience while receiving immunotherapy for cancer.

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

OHSU Knight Cancer Institute100 participantsStarted Sep 2023

Portland, Oregon, United States

Active Not RecruitingPhase 2< 1 mile

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

NCT06018428

Part A is a randomized, double-blind, placebo-controlled, multi-center Proof-of-Concept (POC) Trial in subjects with severe Alopecia Areata. All participants in Part A have completed participation. Part B is a multicenter, open-label study to assess the efficacy, safety, and tolerability of bempikibart (ADX-914) in participants with severe Alopecia Areata.

Alopecia Areata

Q32 Bio Inc.75 participantsStarted Sep 2023

Scottsdale, Arizona, United States • Fayetteville, Arkansas, United States • Hot Springs, Arkansas, United States +30 more locations

Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Find Trials by Condition in Portland

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Clinical Validation Study of the Eximis CS (Contained Segmentation) System

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Influence of Yogic Breathwork on CSF Circulation

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men

Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)

OCS Heart Perfusion Post-Approval Registry

Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia